Cold fever

Article Abstract:

The Anglo-Australian team of two companies, Glaxo Wellcome and Biota, were disappointed by the US Food and Drug Administration's (FDA) decision to reject the flu medication Relenza. The rejection affected the stock price of the companies. Relenza, which is inhaled, has been accepted in Australia and Europe and is an effective medication without side effects. The FDA has agreed to rehear the case. The FDA is also scheduled to review a flu medication developed by a US-Swiss team.

United States, Europe, Care and treatment, Laws, regulations and rules, Product introduction, Influenza, Glaxo Wellcome PLC, Relenza (Medication), Biota

---

Death of the salesman

Article Abstract:

Issues concerning electronic commerce and its impact on the courier services industry are described. New technologies being introduced into the courier market include online ordering and real-time inventory tracking, and the marketing strategies of United Parcel Service of America Inc., Federal Express Corp., and DHL Airways Inc. are examined.

Statistical Data Included, Research, Management, Innovations, Marketing, Electronic commerce, E-commerce, Postal service, Shipping industry, Courier services, Express delivery services, Distribution of goods, Distribution (Commerce), United Parcel Service of America Inc., FedEx Express, Delivery of goods, Deliveries (Transportation), DHL Airways Inc.

---

Similar abstracts:

• Abstracts: Rust never sleeps. Out of the shadows. A world first for World.Net services
• Abstracts: New world e-order. Power of more than one. Holden steers a risky course
• Abstracts: waging war. Two out of three is bad. PAYE attention: useful tips on reducing your PAYE tax burden
• Abstracts: The sum of our parts. Invasion of the body snatchers
• Abstracts: Turning point. Master of the Universe. Strine of the times

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.